Diabetes Mellitus, Type 2 Clinical Trials in Stanford, California

4 studies are recruiting for diabetes mellitus, type 2 in Stanford, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

   Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Board of Trustees of the Leland Stanford Junior University, Stanford, California

   Locations

   4 in total

   Run by

   Stanford University

   See if you can join NCT06251323 on ClinicalTrials.gov

2. Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

   This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether adipocyte-directed t…

   Stage

   Phase 4

   Ages

   30 to 70

   Site

   Stanford University, Clinical and Translational Research Unit (CTRU), Stanford, California

   Locations

   2 in total

   Run by

   Stanford University

   See if you can join NCT06657209 on ClinicalTrials.gov

3. Post Prandial Individual Responses to Different Foods

   This study aims to understand why people respond differently to the same foods, especially when it comes to changes in blood sugar after eating. A continuous glucose monitors (CGMs) will be used to observe how individuals respond to specific meals and drinks (e.g., Oral Glucose Tolerance Test, OGTT…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Stanford University, Stanford, California

   Run by

   Stanford University

   See if you can join NCT06989164 on ClinicalTrials.gov

4. Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

   This 12-week controlled diet and weight intervention study seeks to define the molecular pathways that link excess body weight to the development of insulin resistance (IR). Blood, adipose and stool are sampled at three timepoints; baseline, peak weight (4 weeks) and post weight loss to monitor cha…

   Stage

   Not phased

   Ages

   35 to 65

   Site

   Stanford University, Stanford, California

   Run by

   Stanford University

   See if you can join NCT05165706 on ClinicalTrials.gov